MYP_088863
Daptomycin
Antimicrobial
Antimicrobial
▸
Antibacterial
Antimicrobial
▸
Antibacterial
▸
Anti-Gram-positive
Standard
13 amino acids
C61H84N16O26
Standard
WNDTGKDADGSEY
1457.41 Da
4.05
-3.24
-3.45
-0.2489
-1.85
0.35
-0.25
2.38
7.69
0.1538
6990.00
6990.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
707.31
-9.16
24.0
23.0
46.0
103.0
3.0
13.0
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0361078
VERIFIED: YES
Provenance & Taxonomy
Streptomyces roseosporus [Bacterium]; Bacteria [Bacterium]
2; 2
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antimicrobial
RECORD: Rec_0378360
VERIFIED: YES
Provenance & Taxonomy
Streptomyces roseosporus [Bacterium]
Bacteriocin
Structure & Mods
cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antimicrobial
Antibacterial
Anti-Gram-positive
Gram-positive
RECORD: Rec_0380287
VERIFIED: YES
Provenance & Taxonomy
Streptomyces roseosporus [Bacterium]
Structure & Mods
head-to-tail cyclic peptide [Cyclic]
mixed L/D amino-acid peptide [Mixed]
Lipidation
Esterification
Daptomycin was approved by FDA in 2003 to treat soft-tissue infections, and in 2006 to treat S. aureus bacteremia and right-sided endocarditis. Warning: the sequence is a close mimic of the natural counterpart. Chemical modification: The natural form is cyclic due to the ester bond between the hydroxyl of T4 and the carboxyl of kynurenine-13 (represented by Y here). In daptomycin, the N-terminus is lipidated with n-decanoyl fatty acid chain to replace the C11 branched fatty acid in the natural form of A21978C1 (Eliopoulos GM et al., 1985). Other nonstandard amino acids include ornithine-6 (represented with K), (2S,3R)-3-methyl-glutamic acid-12 (represented with E), and three D-amino acids at positions N2, A8, and S11
Bio-Activity Profile
Antimicrobial
group G. streptococci
<0.06 μg/mL
MIC
RECORD: Rec_0396677
VERIFIED: YES
Provenance & Taxonomy
Streptomyces roseosporus [Bacterium]
Structure & Mods
head-to-tail cyclic peptide [Cyclic]
mixed L/D amino-acid peptide [Mixed]
Lipidation
Esterification
Daptomycin was approved by FDA in 2003 to treat soft-tissue infections, and in 2006 to treat S. aureus bacteremia and right-sided endocarditis. Warning: the sequence is a close mimic of the natural counterpart. Chemical modification: The natural form is cyclic due to the ester bond between the hydroxyl of T4 and the carboxyl of kynurenine-13 (represented by Y here). In daptomycin, the N-terminus is lipidated with n-decanoyl fatty acid chain to replace the C11 branched fatty acid in the natural form of A21978C1 (Eliopoulos GM et al., 1985). Other nonstandard amino acids include ornithine-6 (represented with K), (2S,3R)-3-methyl-glutamic acid-12 (represented with E), and three D-amino acids at positions N2, A8, and S11
Bio-Activity Profile
Antimicrobial
S. agalactiae
0.25-0.5 μg/mL
MIC
RECORD: Rec_0402037
VERIFIED: YES
Provenance & Taxonomy
Streptomyces roseosporus [Bacterium]
Structure & Mods
head-to-tail cyclic peptide [Cyclic]
mixed L/D amino-acid peptide [Mixed]
Lipidation
Esterification
Daptomycin was approved by FDA in 2003 to treat soft-tissue infections, and in 2006 to treat S. aureus bacteremia and right-sided endocarditis. Warning: the sequence is a close mimic of the natural counterpart. Chemical modification: The natural form is cyclic due to the ester bond between the hydroxyl of T4 and the carboxyl of kynurenine-13 (represented by Y here). In daptomycin, the N-terminus is lipidated with n-decanoyl fatty acid chain to replace the C11 branched fatty acid in the natural form of A21978C1 (Eliopoulos GM et al., 1985). Other nonstandard amino acids include ornithine-6 (represented with K), (2S,3R)-3-methyl-glutamic acid-12 (represented with E), and three D-amino acids at positions N2, A8, and S11
Bio-Activity Profile
Antimicrobial
S. pneumoniae
<0.06-0.125 μg/mL
MIC
Showing 5 records on this page · Page 2 of 2